GNP

利钠肽

Report date: 2023/09/12 20:11:36
NME

Base Information

Drug NameGNP
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNatriuretic peptide receptor 1 agonists
TargetsNatriuretic peptide receptor 1
Therapy Area/IndicationsAcutely decompensated congestive heart failureHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesGuangzhou Leien Kangya Biomedical Technology Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesGuangzhou Leien Kangya Biomedical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsAcutely decompensated congestive heart failureHeart Failure
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A